Table 1.
Patients’ characteristics during the 2019 and 2020 study periods.
| 2019 (n = 229) | 2020 (n = 222) | P | |
|---|---|---|---|
| Age (years) | 33 ± 5.1 | 33.6 ± 4.9 | 0.21 |
| Body mass index (kg/m2) | 28.1 ± 6.3 | 28.6 ± 6.2 | 0.40 |
| Gestational age at inclusion (WA) | 30.4 (23.1–34.9) | 31.3 (25.4–35.7) | 0.066 |
| Capillary blood sugar (mg/dL) | 147.0 (69.0–218.0) | 170.5 (68.0–242.0) | 0.49 |
| Preprandial glycaemic values (mean, mmol/L) | 4.7 ± 0.3 | 4.7 ± 0.3 | 0.40 |
| Postprandial glycaemic values (mean, mmol/L) | 5.9 ± 0.5 | 5.9 ± 0.6 | 0.12 |
| Preprandial patients with values ≥5.1 mmol/L | |||
| <20% (good diabetes control) | 156 (68.1) | 146 (65.8) | 0.58 |
| 20–40% (acceptable diabetes control) | 48 (21.0) | 49 (22.1) | |
| > 40% (poor diabetes control) | 25 (10.9) | 27 (12.2) | |
| Postprandial patients with values ≥6.6 mmol/L | |||
| <20% (good diabetes control) | 159 (69.4) | 135 (61.6) | 0.049 |
| 20–40% (acceptable diabetes control) | 50 (21.8) | 54 (24.7) | |
| >40% (poor diabetes control) | 20 (8.7) | 30 (13.7) | |
| Patients receiving insulin therapy | 83 (36.2) | 106 (47.7) | 0.013 |
Results are means ± standard deviation, medians (interquartile range) or n (%); between-group comparisons were by chi-square, Cochran–Armitage, Student's or Mann–Whitney U tests; P ≤ 0.05 considered statistically significant; WA, weeks of amenorrhoea.